$SNOVF:OTC $KBEV:CSE, Koios Beverage arranges up to $5M
$SNOVF:OTC $KBEV:CSE, Koios Beverage arranges up to $5M
2018-05-03 06:27 PT - News Release
Mr. Chris Miller reports
KOIOS BEVERAGE CORP. ANNOUNCES PRIVATE PLACEMENT UP TO $5-MILLION
Koios Beverage Corp. has arranged a non-brokered private placement financing of common shares of the company at a price of 40 cents per share for gross proceeds of a minimum of $2.5-million and up to a maximum of $5-million.
Completion of the offering is subject to a number of conditions, including, without limitation, receipt of all necessary regulatory approvals. Finders' fees may be paid in connection with the offering.
All securities issued in connection with the offering will be subject to a statutory hold period of four months and one day from the date of issuance in accordance with applicable securities legislation. The company clarifies that further to its news release dated April 13, 2018, all shares issued in connection with the concurrent financing that closed on April 13, 2018, are not subject to any hold period.
About the company's business
The company, through its wholly owned subsidiary Koios Inc., is an emerging functional beverage company which has an available distribution network of more than 2,000 retail locations across the United States in which to sell its products.
We seek Safe Harbor.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Concerns About Cryptocurrency Announcements Prominent economist and market commentator Peter Schiff has urged a Congressional investigation into President Donald Trump's recent foray into cryptocurrency, suggesting that these announcements may involve insider trading and market manipulation. The Key Questions Raised In a recent post on X, Schiff sought answers to several...
Continue Reading
BriaCell Enters MSK’s 2025 Therapeutics Accelerator Program BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, TSX: BCT) is thrilled to share the news of its selection into the Memorial Sloan Kettering Cancer Center (MSK) Therapeutics Accelerator Program for 2025. This prestigious program is designed to fast-track the clinical development of many innovative cancer...
Continue Reading
Understanding Net Asset Value (NAV) in Investment Funds Net Asset Value (NAV) is a crucial metric for evaluating the performance of investment funds, representing the value of a fund's assets minus its liabilities. It's important for investors to keep track of NAV as it aids in making informed decisions regarding their investments. Here, we delve into the recent NAVs of...
Continue Reading
Introduction to DoorDash's Expansion DoorDash (NASDAQ: DASH) has recently unveiled exciting developments regarding its Commerce Platform. This significant enhancement is set to assist restaurants in boosting direct sales while fostering better customer relationships across multiple channels. New Features for Restaurant Success The introduced tools are designed to uplift...
Continue Reading
Positive News for Udenafil in Kidney Disease New updates from Mezzion Pharma Co., Ltd. have come across quite promising. They've reported some favorable results in a preclinical study of udenafil, targeting autosomal dominant polycystic kidney disease (ADPKD). It appears that this PDE5 inhibitor, typically used in aiding cardiovascular issues, now shows potential in...
Continue Reading